A Study Assessing HMB-002 in Participants With Von Willebrand Disease

NCT06754852 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Von Willebrand Disease (VWD)
Von Willebrand Disease (VWD), Type 1
Von Willebrand Disease (VWD), Type 2

Interventions

DRUG: HMB-002 (Part A)
DRUG: HMB-002 (Part B)

Sponsor

Hemab ApS